uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Strong conservation of the human NF2 locus based on sequence comparison in five species
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Genetics and Pathology.
Show others and affiliations
2003 In: Mammalian Genome, ISSN 0938-8990, Vol. 14, no 8, 526-536 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2003. Vol. 14, no 8, 526-536 p.
URN: urn:nbn:se:uu:diva-94067OAI: oai:DiVA.org:uu-94067DiVA: diva2:167788
Available from: 2006-03-10 Created: 2006-03-10Bibliographically approved
In thesis
1. Analysis of Genetic Alterations in Patients Affected with Neurofibromatosis Type 2 and its Associated Tumors
Open this publication in new window or tab >>Analysis of Genetic Alterations in Patients Affected with Neurofibromatosis Type 2 and its Associated Tumors
2006 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder with the clinical hallmark of bilateral vestibular schwannomas (VS). Patients affected by a severe NF2 phenotype also presents with peripheral schwannomas, meningiomas and ependymomas. The closely related disorder schwannomatosis also displays multiple schwannomas, but never VS. Mutation screening of the NF2 gene in the above mentioned tumors did not identify mutations in numerous of cases. We analyzed the DNA sequence covering the NF2 locus in order to identify evolutionarily conserved non-genic sequences (CNGs) with unknown regulatory function (paper I). The aim was to analyze CNGs for mutations in DNA derived from patients affected by NF2 associated tumors. During mutation analysis of the coding part of NF2 and within the CNGs defined in paper I, were mutations detected in 39% of sporadic meningiomas (paper II). Two candidate regions were identified on 22q using array-CGH. Methylation profiling did not identify methylation of the NF2 promoter in these tumors. Sporadic schwannomas were profiled for CNV using a 22q genomic array in the search for putative gene(s) that in addition to NF2 could be involved in the development of schwannoma and/or schwannomatosis (paper III). The predominant aberration identified was monosomy 22. Terminal and interstitial deletions encompassing the NF2 gene were detected in tumor DNA and eight loci affected by CNV in constitutional DNA. Some of these CNVs are unlikely to be phenotypically neutral, considering their size and gene content. Two schwannomatosis candidate regions were identified on 22q using array-CGH (paper IV). These regions were further characterized by a PCR-product based array with higher resolution. Rearrangements of the immunoglobulin lambda (IGL) locus detected were restricted to schwannomatosis patients. In the second candidate region spanning GSTT1 and CABIN1 genes, was frequent copy number polymorphism at the GSTT1 locus identified. We further describe missense mutations in the CABIN1 gene, making this gene a plausible candidate which may contribute to the pathogenesis of these disorders.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2006. 58 p.
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 113
Molecular biology, Neurofibromatosis type 2, schwannoma, schwannomatosis, meningioma, array-CGH, chromosome 22, DNA copy number variation, methylation, Molekylärbiologi
National Category
Biochemistry and Molecular Biology
urn:nbn:se:uu:diva-6511 (URN)91-554-6477-7 (ISBN)
Public defence
2006-03-31, Rudbecksalen, Rudbeck laboratoriet, Dag Hammarskjöldsväg 20, Uppsala, 09:15
Available from: 2006-03-10 Created: 2006-03-10 Last updated: 2011-02-15Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Genetics and Pathology

Search outside of DiVA

GoogleGoogle Scholar

Total: 142 hits
ReferencesLink to record
Permanent link

Direct link